Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease?

Mov Disord. 2019 Jun;34(6):816-819. doi: 10.1002/mds.27691. Epub 2019 Apr 14.

K Ray Chaudhuri^{1

2}, Peter Jenner³, Angelo Antonini⁴

¹ King's College London, Department of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, London, United Kingdom.
² National Parkinson Foundation Centre of Excellence, King's College Hospital, Denmark Hill, London, United Kingdom.
³ Neurodegenerative Diseases Research Group, School of Cancer and Pharmaceutical Sciences, Faculty of Life Science and Medicine, King's College London, London, United Kingdom.
⁴ Department of Neuroscience, University of Padova, Padova, Italy.

No abstract available

MeSH terms